ATE308343T1 - Trägerhilfstoff - Google Patents

Trägerhilfstoff

Info

Publication number
ATE308343T1
ATE308343T1 AT99929812T AT99929812T ATE308343T1 AT E308343 T1 ATE308343 T1 AT E308343T1 AT 99929812 T AT99929812 T AT 99929812T AT 99929812 T AT99929812 T AT 99929812T AT E308343 T1 ATE308343 T1 AT E308343T1
Authority
AT
Austria
Prior art keywords
carrier aid
aid
carrier
whiteness
trehalose
Prior art date
Application number
AT99929812T
Other languages
English (en)
Inventor
Kazuhiro Oobae
Etsuo Kamada
Shun Ichi Gomi
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Application granted granted Critical
Publication of ATE308343T1 publication Critical patent/ATE308343T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Glass Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT99929812T 1998-07-15 1999-07-13 Trägerhilfstoff ATE308343T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20029598 1998-07-15
JP32356098 1998-11-13
PCT/JP1999/003775 WO2000003735A1 (fr) 1998-07-15 1999-07-13 Excipient

Publications (1)

Publication Number Publication Date
ATE308343T1 true ATE308343T1 (de) 2005-11-15

Family

ID=26512084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929812T ATE308343T1 (de) 1998-07-15 1999-07-13 Trägerhilfstoff

Country Status (10)

Country Link
US (1) US6699845B2 (de)
EP (1) EP1097722B1 (de)
JP (1) JP4748627B2 (de)
KR (1) KR100421264B1 (de)
CN (1) CN1185013C (de)
AT (1) ATE308343T1 (de)
AU (1) AU743109B2 (de)
CA (1) CA2337015C (de)
DE (1) DE69928110T2 (de)
WO (1) WO2000003735A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
EP1460080A1 (de) * 2003-03-21 2004-09-22 Cargill Incorporated Direkt komprimierbare Trehalose in fester Form
WO2004084650A1 (ja) * 2003-03-26 2004-10-07 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 非糖質成分の粉末化方法及び粉末化基剤
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
JP2007131587A (ja) * 2005-11-11 2007-05-31 Activas Pharma:Kk キノリノン誘導体を有効成分とする医薬組成物、及びその製造方法
UA92052C2 (ru) * 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
CN100391541C (zh) * 2006-03-16 2008-06-04 南台科技大学 以胶质类食材制造赋形剂的方法
JP5535616B2 (ja) * 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
CA2810839A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh A polymorphic form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(r)-amino-piperidin-1-yl)-xanthine
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
TWI492747B (zh) * 2006-06-27 2015-07-21 Daiichi Sankyo Co Ltd 壓縮製劑
US20100092564A1 (en) * 2006-12-21 2010-04-15 Jae Han Park Composition of and Method for Preparing Orally Disintegrating Tablets
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP5344938B2 (ja) * 2009-01-29 2013-11-20 旭化成ケミカルズ株式会社 崩壊性固形製剤
CN107115530A (zh) 2009-11-27 2017-09-01 勃林格殷格翰国际有限公司 基因型糖尿病患者利用dpp‑iv抑制剂例如利拉利汀的治疗
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
MY160496A (en) * 2011-09-21 2017-03-15 Hayashibara Co Process for producing a particulate composition comprising crystalline trehalose dihydrate
US9522964B2 (en) * 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
AU2018344621B8 (en) 2017-10-03 2020-07-23 Mizkan Holdings Co., Ltd. Composition containing fine food particulate complexes, and method for producing same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678812A (en) 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
DE69331839T2 (de) 1992-01-29 2002-12-12 Takeda Chemical Industries Ltd Schnellösliche Tablette und ihre Herstellung
ATE210968T1 (de) 1992-02-18 2002-01-15 Nippon Shinyaku Co Ltd Verfahren zur herstellung von schnelllöslicher tabletten und schnelllöslichen tablette beinhaltend xylitol
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
DK0691344T3 (da) 1992-12-28 2003-07-14 Hayashibara Biochem Lab Oprensning af trehalose
JP3773062B2 (ja) * 1993-01-29 2006-05-10 味の素株式会社 製剤用添加剤
JP3559585B2 (ja) * 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
EP0745382B1 (de) 1994-01-31 2003-11-12 Yamanouchi Pharmaceutical Co. Ltd. Intraoral löslicher formpressling und verfahren zu seiner herstellung
JP3534130B2 (ja) * 1994-03-01 2004-06-07 旭化成ケミカルズ株式会社 医薬品組成物
IL114030A (en) * 1994-06-27 2000-08-13 Hayashibara Biochem Lab Saccharide composition with a lesser reducibility its preparation and compositions containing it
JP3616166B2 (ja) 1994-07-19 2005-02-02 株式会社林原生物化学研究所 トレハロースとその製造方法並びに用途
JP2919771B2 (ja) 1995-04-17 1999-07-19 佐藤製薬株式会社 速溶解性錠剤の製造方法及び該製造方法により製造した速溶解性錠剤
JP3418274B2 (ja) 1995-06-05 2003-06-16 日本化薬株式会社 口腔内感触の良好な錠剤
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
CA2204599A1 (en) 1995-09-07 1997-03-13 Otsuka Pharmaceutical Co., Ltd. Low-pressure tableted effervescent preparation
JP3624038B2 (ja) * 1995-12-11 2005-02-23 株式会社林原生物化学研究所 糖衣固形物及びその製造方法
BR9714509A (pt) * 1996-02-09 2000-03-21 Quadrant Holdings Cambridge Formulações sólidas contendo trealose
JPH09316006A (ja) 1996-05-29 1997-12-09 Yatsuken:Kk 口腔内溶解性固形製剤
JP3797387B2 (ja) 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JPH11116464A (ja) 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 迅速溶解性固形製剤およびその製造法

Also Published As

Publication number Publication date
KR100421264B1 (ko) 2004-03-18
JP4748627B2 (ja) 2011-08-17
WO2000003735A1 (fr) 2000-01-27
US6699845B2 (en) 2004-03-02
KR20010071883A (ko) 2001-07-31
CA2337015C (en) 2004-09-07
AU4651699A (en) 2000-02-07
EP1097722A1 (de) 2001-05-09
CN1309570A (zh) 2001-08-22
DE69928110D1 (de) 2005-12-08
EP1097722A4 (de) 2002-03-20
DE69928110T2 (de) 2006-07-27
CA2337015A1 (en) 2000-01-27
EP1097722B1 (de) 2005-11-02
US20020042393A1 (en) 2002-04-11
AU743109B2 (en) 2002-01-17
CN1185013C (zh) 2005-01-19

Similar Documents

Publication Publication Date Title
ATE308343T1 (de) Trägerhilfstoff
CY1108948T1 (el) Διαταξεις ηλεκτροφωταυγειας
EA199900318A1 (ru) Способ производства гранул цеолита х с низким содержанием двуокиси кремния с низким содержанием инертного связующего
IL132238A0 (en) Fungicidal trifluromethylalkylamino - triazolopyrimidines
GR3025639T3 (en) Porous inorganic ultrasound contrast agents
HUP9903536A2 (hu) Bázikus anyaggal stabilizált gyógyászati készítmények
NZ508797A (en) Particles of HCV envelope proteins: use for vaccination
AU5792690A (en) Aqeous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
EA199900467A2 (ru) Составы на основе зипразидона
ES2191616T3 (es) Polvos pulverizables de fluoropolimeros no fibrilables.
BG101893A (en) Nodulosporic acid derivatives
AU2447288A (en) Drug carriers
MXPA04000849A (es) Composicion cristalina que contiene escitalopram.
EP1435395A4 (de) Eisenmetallgranulat
ATE172116T1 (de) Pharmazeutische anthocyanoside enthaltende zusammensetzungen zur oralen anwendung
MXPA04003199A (es) Composicion que contiene particulas para estilizar el cabello.
HU9501524D0 (en) Insecticidal and acaricidal suspension concentrate containing arylpyrrole derivatives
SG63757A1 (en) Adding impurities to improve the efficiency of allngan quantum well led's
GR3033728T3 (en) Tablets containing thioctic acid with a specified size.
AR016099A1 (es) Composiciones detergentes liquidas no acuosas que contienen particulas enzimaticas que tienen densidad reducida
FI952629A (fi) Kefiksiimivalmiste
DE69423402T2 (de) Stabile, pharmazeutische Zusammensetzungen die hybrid alpha-Interferon enthalten
AU3315200A (en) 1,5-anhydro-d-fructose substituted with a hydrophobic group for use as anti-oxidant and/or emulsifier
EP1043387A3 (de) Alkylbenzolsulfonat-Granulate
TR200003413A2 (tr) Granüler organosilan hazır ürün, bunun üretimi için bir işlem ve kullanımı

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties